Morning Briefing
Summaries of health policy coverage from major news organizations
Perspectives: WHO Recommends New Malaria Vaccine, So Why The Hesitancy?
One child dies every two minutes from malaria. Wider use of a new vaccine can make a dent in that devastating statistic. (Marian W. Wentworth and Thomas Hall, 10/10)
A little over a decade ago, our group tested a simple idea: Could we fight cancer cells using cells that we changed? We armed these killer immune cells — T cells — with a tailor-made receptor so they could see and kill cancer. This treatment, called CAR T therapy, worked even better than we could have hoped. (Daniel Baker and Carl June, 10/8)
Congress has taken the necessary step of including critical reauthorizations for the Prescription Drug User Fee Act in its continuing resolution that will avert a partial government shutdown. (David F. Arons, 10/10)
While most people assume that all Federal Drug Administration-approved drugs are equally safe and effective, research shows that this is not always true. The reality is that the FDA tests only a small fraction of generic drugs sold in the U.S. each year. (Rosemary Gibson and John V. Gray, 10/6)
